Connect Education Workshop Details

Update on Lymphoma Treatment from the 2009 American Society of Hematology (ASH) Annual Meeting

Topic:	Cancer Type
Cancer Type:	Lymphoma
Date:	December 15, 2009
Time:	1:30 p.m. - 2:30 p.m. ET
Presented By:	John P. Leonard, MD Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Cornell Medical College, Clinical Director, New York-Cornell Center for Lymphoma and Myeloma, Chief, Lymphoma-Myeloma Service, Associate Director for Clinical Research, Weill Cornell Cancer Center Oliver W. Press, MD, PhD Member, Fred Hutchinson Cancer Research Center, Recipient, Dr. Penny E. Petersen Memorial Chair for Lymphoma Research, Professor of Medicine, University of Washington, Co-Chair, NCI Lymphoma Steering Committee Julie M. Vose, MD Neumann M. and Mildred E. Harris Professor, Chief, Section of Hematology/Oncology, Professor of Medicine, University of Nebraska Medical Center Jennifer Mills, MSW, MPH National Director, Patient Programs, Lymphoma Research Foundation Richard Dickens, MSW Program Coordinator of Blood Cancers, Project Coordinator, Mind/Body Program, CancerCare
Presented in partnership with:	Lymphoma Research Foundation American Cancer Society American Pain Foundation American Society of Clinical Oncology Association of Clinicians for the Underserved Association of Oncology Social Work Black Women's Health Imperative Blood and Marrow Transplant Information Network Cancer Patient Education Network Education Network to Advance Cancer Clinical Trials Gilda's Club Worldwide Intercultural Cancer Council Joe's House - A Lodging Guide for Cancer Patients Multinational Association of Supportive Care in Cancer National Bone Marrow Transplant Link National Center for Frontier Communities National Coalition for Cancer Survivorship National Family Caregivers Association National Marrow Donor Program Research Advocacy Network Vital Options International & The Group Room The Wellness Community
This program is made possible by:	Supported by unrestricted educational grants to Lymphoma Research Foundation from Cephalon Oncology, Genentech, Inc. and Millennium: The Takeda Oncology Company.